Author

M. Pirazzini

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Grinzato· 1 shared A. Lanzavecchia· 1 shared C. Montecucco· 1 shared C. Silacci Fregni· 1 shared D. Corti· 1 shared E. Kandiah· 1 shared F. Vallese· 1 shared G. Schiavo· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPathology

A. Grinzato

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Extremely potent human monoclonal antibodies for the prophylaxis and therapy of Tetanus

M. Pirazzini, A. Grinzato, D. Corti, S. Barbieri, O. Leka, F. Vallese, M. Tonellato, C. Silacci Fregni, L. Piccoli, E. Kandiah, G. Schiavo, G. Zanotti, A. Lanzavecchia, C. Montecucco

This study identifies two human monoclonal antibodies with high neutralizing activity against tetanus neurotoxin, showing potential for both prophylaxis and therapy.

bioRxiv · May 24, 2021Pathology